Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2026)

Sarepta Therapeutics' Current Taxes history runs 8 years deep, the most recent figure standing at $13.8 million for Q1 2026.

• In Q1 2026, Current Taxes fell 82.73% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $13.8 million (down 82.73% YoY), while the FY2025 annual figure was $4.8 million, down 72.66% from the prior year.
• Current Taxes was $13.8 million for Q1 2026 at Sarepta Therapeutics, up from $4.8 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $79.9 million in Q1 2025 to a low of $4.1 million in Q3 2022.
• Historically, Current Taxes has averaged $19.5 million across 5 years, with a median of $16.1 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Current Taxes soared 5696.76% in 2022, then plunged 82.73% in 2026.
• A 5-year view of Current Taxes shows it stood at $12.5 million in 2022, then grew by 9.94% to $13.8 million in 2023, then advanced by 26.33% to $17.4 million in 2024, then plunged by 72.66% to $4.8 million in 2025, then surged by 189.99% to $13.8 million in 2026.
• The last three Current Taxes figures came in at $13.8 million (Q1 2026), $4.8 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.